ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
K2 Therapeutics raised US$50 million to build a global biotech pipeline from Singapore. The funding supports the company's expansion of its therapeutic development operations based in the city-state.
Tap to vote and see what everyone thinks.
Summary by ByteBrief